Dynamic Technology Lab Private LTD Rubius Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

  • $885 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$9.68 - $17.74 $102,220 - $187,334
-10,560 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$17.6 - $25.91 $185,856 - $273,609
10,560 New
10,560 $189,000
Q3 2020

Nov 13, 2020
SELL
$4.65 - $6.25 $69,015 - $92,762
-14,842 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.01 - $6.88 $59,516 - $102,112
14,842 New
14,842 $89,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email